Effect of Cherry Concentrate on Vascular Function

October 23, 2018 updated by: University of Exeter
Acute effect of cherry concentrate consumption on flow mediated dilatation in healthy young men

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Devon
      • Exeter, Devon, United Kingdom, EX1 2LU
        • Sport & Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • no prescription medications

Exclusion Criteria:

  • prescription medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Cherry
Cherry concentrate
Acute cherry concentrate
Placebo Comparator: Placebo
Placebo concentrate
Acute cherry concentrate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Flow mediated dilatation
Time Frame: Change from baseline to 3 hours post dietary supplementation
Change from baseline to 3 hours post dietary supplementation

Secondary Outcome Measures

Outcome Measure
Time Frame
Microvascular function (laser doppler flowmetry)
Time Frame: Change from baseline to 3 hours post dietary supplementation
Change from baseline to 3 hours post dietary supplementation
Plasma nitrite concentration
Time Frame: Change from baseline to 3 hours post dietary supplementation
Change from baseline to 3 hours post dietary supplementation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (Actual)

January 1, 2018

Study Completion (Actual)

January 1, 2018

Study Registration Dates

First Submitted

December 2, 2016

First Submitted That Met QC Criteria

December 5, 2016

First Posted (Estimate)

December 6, 2016

Study Record Updates

Last Update Posted (Actual)

October 25, 2018

Last Update Submitted That Met QC Criteria

October 23, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 115229/03

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Cherry versus placebo concentrate

3
Subscribe